Literature DB >> 6551160

The fate of neutrophil elastase incorporated by human alveolar macrophages.

S E McGowan, P J Stone, J D Calore, G L Snider, C Franzblau.   

Abstract

Although protease-antiprotease imbalance is widely thought to contribute to the genesis of emphysema, the involvement of the alveolar macrophage in this process is poorly defined. We have quantified the uptake of radioiodinated human neutrophil elastase by human alveolar macrophages in monolayer culture and assessed the enzyme's fate during periods as long as 48 h after uptake using molecular sieve chromatography. Approximately half of the radiolabel eluted with enzymatically inactive material of molecular sizes corresponding to either degraded or alpha1-protease-inhibitor-bound elastase. The remainder of the radiolabel eluted at 29,000 daltons, in fractions containing enzyme that solubilized particulate elastin, and likely represented intact neutrophil elastase. Macrophages from smokers and nonsmokers showed similar characteristics of incorporation and disposition of neutrophil elastase. Lysates of uncultured alveolar macrophages from smokers and nonsmokers contained (mean +/- SE, n = 4) 7.4 +/- 0.8 and 3.3 +/- 1.4 ng of neutrophil elastase activity per 10(6) cells, respectively (not significant). However, as smokers have 11-fold more cells obtainable by lavage, the total lavaged elastase loads in alveolar macrophages were 561.7 +/- 72.3 and 21.3 +/- 6.8 (p less than 0.01) in smokers and nonsmokers, respectively. We conclude that the alveolar macrophage may clear and inactivate neutrophil elastase in the lung. In addition, by conserving some ingested elastase in an enzymatically active form, the macrophage may serve as an elastase reservoir. In areas of high macrophage density, as around the respiratory bronchioles of smokers, the macrophage could release a portion of the incorporated elastase and damage lung elastin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6551160     DOI: 10.1164/arrd.1983.127.4.449

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema.

Authors:  Frank Guarnieri; Jean L Spencer; Edgar C Lucey; Matthew A Nugent; Phillip J Stone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Generation of C5a by phagocytic cells.

Authors:  Markus Huber-Lang; Ellen M Younkin; J Vidya Sarma; Niels Riedemann; Stephanie R McGuire; Kristina T Lu; Robin Kunkel; John G Younger; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema.

Authors:  T Muley; M Wiebel; V Schulz; W Ebert
Journal:  Clin Investig       Date:  1994-03

4.  Neutrophil Elastase Triggers the Release of Macrophage Extracellular Traps: Relevance to Cystic Fibrosis.

Authors:  Apparao B Kummarapurugu; Shuo Zheng; Jonathan Ma; Shobha Ghosh; Adam Hawkridge; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

5.  Mechanisms of serum-enhanced adhesion of human alveolar macrophages to epithelial cells.

Authors:  S E McGowan; J G Heckman
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 6.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

7.  Spotlighting "Neutrophil Elastase Triggers the Release of Macrophage Extracellular Traps": A New Catch in Cystic Fibrosis?

Authors:  My N Helms; Theodore G Liou
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 6.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.